SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-094082
Filing Date
2023-04-06
Accepted
2023-04-06 16:38:02
Documents
13
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d449157d8k.htm   iXBRL 8-K 26776
2 EX-10.1 d449157dex101.htm EX-10.1 27998
  Complete submission text file 0001193125-23-094082.txt   188687

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA grts-20230331.xsd EX-101.SCH 2853
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE grts-20230331_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE grts-20230331_pre.xml EX-101.PRE 11709
7 EXTRACTED XBRL INSTANCE DOCUMENT d449157d8k_htm.xml XML 3456
Mailing Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608
Business Address 5959 HORTON STREET, SUITE 300 EMERYVILLE CA 94608 (510) 871-6100
Gritstone bio, Inc. (Filer) CIK: 0001656634 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38663 | Film No.: 23806695
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences